Im not defending the company at all... Ive pointed out many, many concerns I have. However, I am interested in the science and seeing what comes of the next study, if it ever happens
The previous discussion was regarding the Phase 1 cohort and their clinical profile
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.